Proteomics of Papillary Thyroid Carcinoma
Proteomics of Papillary Thyroid Carcinoma
Thyroid carcinoma is the common endocrine system malignant neoplasm. At present it has become
 the malignant neoplasm of fastest growing incidence rate. More than 85% thyroid carcinoma is
 papillary thyroid carcinoma. Cervical lymph node metastasis is common in papillary thyroid
 carcinoma patients. This study aim to reveal protein expression differences between papillary
 thyroid carcinoma with cervical lymph node metastasis and without cervical lymph node
 metastasis.
1. Object: Patients aged 18-65 years; newly diagnosed papillary thyroid carcinoma with
 cervical lymph node metastasis and without cervical lymph node metastasis and undergone
 thyroidectomy according to the China thyroid association guidelines for the Management
 of thyroid nodule and thyroid cancer.

 2. Clinical information, examination data: Information is obtained from medical record
 abstraction.

 3. Samples: Fresh frozen thyroid tissues from each sample group(normal histology, benign
 disease, papillary thyroid carcinoma with cervical lymph node metastasis, papillary
 thyroid carcinoma without cervical lymph node metastasis ).
Inclusion Criteria:

 -  Newly diagnosed papillary thyroid carcinoma.

 -  Undergo thyroidectomy according to the China thyroid association guidelines forthe
 Management of thyroid nodule and thyroid cancer.

 Exclusion Criteria:

 -  Current substance abuse/dependence.

 -  Daily tobacco and alcohol use.

 -  Whole neck irradiation or surgery.

 -  Prior cancer diagnosis or chemotherapy treatment.

 -  Active autoimmune disorder.

 -  Uncontrolled allergic condition or asthma.

 -  Chronic use of oral steroid medication.

 -  Hormone therapy (estrogen, progestin compounds).